Ongoing research aims to better understand the underlying mechanisms of SMA and to develop more effective treatments. Areas of focus include gene therapy, stem cell therapy, and new pharmacological approaches to enhance SMN protein production. Clinical trials are continuously being conducted to find new ways to improve patient outcomes.
